Lack of Access to Abortion Has Had a Negative Impact on Cancer Care
Since the US Supreme Court overturned Roe v Wade last year, restrictions on access to abortion have had a negative impact on cancer care.
Hematologic Cancer
HEMATOLOGIC CANCER ADVISOR
FEATURED CONTENT
-
-
Ibrutinib No Longer Approved for MCL, MZL: How This Change Will Affect Patients
The withdrawn approvals of ibrutinib for relapsed/refractory MCL and MZL are likely to have a limited impact on patients, experts say. -
ART and Pediatric Cancer: Risk May Vary by Method Used, Cancer Type
Research has suggested that ART may increase the risk of pediatric cancers, but studies have shown conflicting results, and questions remain. -
Preventing and Treating COVID-19 in Cancer Patients: Challenges in the Omicron Era
Methods to prevent and treat COVID-19 in cancer patients have had to evolve alongside the SARS-CoV-2 virus. -
Sexual Health and Cancer: What Providers Need to Know
Sexual dysfunction may be common in cancer patients and survivors, but their sexual health is often overlooked.
HEMATOLOGIC CANCER NEWS
CIRS-G Reveals Accelerated Aging, Early Death in Childhood Cancer Survivors
Pirtobrutinib Produces Durable Responses in Relapsed/Refractory MCL
Childhood Cancer Survivors Have Higher Risk of Late Surgical Interventions
AYA Cancer Survivors Have Increased Risk of HPV-Linked Subsequent Cancer
Epkinly Approved for Relapsed, Refractory Diffuse Large B-Cell Lymphoma
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Hematologic Cancers
Loading... 
Loading...